Weeks 1 to 4 (loading phase): TB-500: 2.5 mg subcutaneous, twice weekly GHK-Cu (injectable, if prescribed): 1 mg subcutaneous, three times weekly GHK-Cu (topical, over wound or scar): 2% cream once daily Weeks 5 to 8 (maintenance phase): TB-500: 2 mg subcutaneous, once weekly GHK-Cu (injectable): 0.5 mg subcutaneous, twice weekly GHK-Cu (topical): continued as tolerated Weeks 9 to 12 (taper and assess): TB-500: 2 mg subcutaneous, once every two weeks GHK-Cu (injectable): discontinue or continue at 0.5 mg once weekly based on clinical response GHK-Cu (topical): continue indefinitely if cosmetic goal is active A 12-week total cycle is the most common practitioner-reported duration
Most people report seeing improvements with energy, sleep, and pain relief within the first few weeks
Eventually, the skin begins to lose some of its renewed firmness and enhanced texture, leading to the need to make a new appointment
Fase kedua adalah proses detoksifikasi lanjutan dari fase pertama yang melibatkan berbagai enzim
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis
1:500) or mouse anti-DNA (Progen, 61014